These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

892 related items for PubMed ID: 19176440

  • 1. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
    Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, Yoon SI, Suter T, Osterhues HH, Schieber MM, Hilti P, Schindler R, Brunner-La Rocca HP, TIME-CHF Investigators.
    JAMA; 2009 Jan 28; 301(4):383-92. PubMed ID: 19176440
    [Abstract] [Full Text] [Related]

  • 2. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S, Maeder MT, Nietlispach F, Rickli H, Estlinbaum W, Erne P, Rickenbacher P, Peter M, Pfisterer MP, Brunner-La Rocca HP, TIME-CHF Investigators.
    Circ Heart Fail; 2014 Jan 28; 7(1):131-9. PubMed ID: 24352403
    [Abstract] [Full Text] [Related]

  • 3. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF).
    Maeder MT, Rickenbacher P, Rickli H, Abbühl H, Gutmann M, Erne P, Vuilliomenet A, Peter M, Pfisterer M, Brunner-La Rocca HP, TIME-CHF Investigators.
    Eur J Heart Fail; 2013 Oct 28; 15(10):1148-56. PubMed ID: 23657728
    [Abstract] [Full Text] [Related]

  • 4. Management of elderly patients with congestive heart failure--design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).
    Brunner-La Rocca HP, Buser PT, Schindler R, Bernheim A, Rickenbacher P, Pfisterer M, TIME-CHF-Investigators.
    Am Heart J; 2006 May 28; 151(5):949-55. PubMed ID: 16644310
    [Abstract] [Full Text] [Related]

  • 5. Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF.
    Sanders-van Wijk S, Muzzarelli S, Neuhaus M, Kiencke S, Maeder M, Estlinbaum W, Tobler D, Mayer K, Erne P, Pfisterer ME, Brunner-La Rocca HP, TIME-CHF investigators.
    Eur J Heart Fail; 2013 Aug 28; 15(8):910-8. PubMed ID: 23666681
    [Abstract] [Full Text] [Related]

  • 6. N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF.
    Davarzani N, Sanders-van Wijk S, Karel J, Maeder MT, Leibundgut G, Gutmann M, Pfisterer ME, Rickenbacher P, Peeters R, Brunner-la Rocca HP.
    J Card Fail; 2017 May 28; 23(5):382-389. PubMed ID: 28232046
    [Abstract] [Full Text] [Related]

  • 7. Brain natriuretic peptide-guided treatment does not improve morbidity and mortality in extensively treated patients with chronic heart failure: responders to treatment have a significantly better outcome.
    Karlström P, Alehagen U, Boman K, Dahlström U, UPSTEP-study group.
    Eur J Heart Fail; 2011 Oct 28; 13(10):1096-103. PubMed ID: 21715446
    [Abstract] [Full Text] [Related]

  • 8. Can BNP-guided therapy improve health-related quality of life, and do responders to BNP-guided heart failure treatment have improved health-related quality of life? Results from the UPSTEP study.
    Karlström P, Johansson P, Dahlström U, Boman K, Alehagen U.
    BMC Cardiovasc Disord; 2016 Feb 13; 16():39. PubMed ID: 26905220
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure).
    Sanders-van Wijk S, van Asselt AD, Rickli H, Estlinbaum W, Erne P, Rickenbacher P, Vuillomenet A, Peter M, Pfisterer ME, Brunner-La Rocca HP, TIME-CHF Investigators.
    JACC Heart Fail; 2013 Feb 13; 1(1):64-71. PubMed ID: 24621800
    [Abstract] [Full Text] [Related]

  • 10. B-type natriuretic peptide. Guided vs. conventional care in outpatients with chronic heart failure: a retrospective study.
    De Vecchis R, Esposito C, Di Biase G, Ariano C.
    Minerva Cardioangiol; 2013 Aug 13; 61(4):437-49. PubMed ID: 23846010
    [Abstract] [Full Text] [Related]

  • 11. Quality of life and chronic heart failure therapy guided by natriuretic peptides: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study.
    Bhardwaj A, Rehman SU, Mohammed AA, Gaggin HK, Barajas L, Barajas J, Moore SA, Sullivan D, Januzzi JL.
    Am Heart J; 2012 Nov 13; 164(5):793-799.e1. PubMed ID: 23137512
    [Abstract] [Full Text] [Related]

  • 12. Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study.
    Eurlings LW, van Pol PE, Kok WE, van Wijk S, Lodewijks-van der Bolt C, Balk AH, Lok DJ, Crijns HJ, van Kraaij DJ, de Jonge N, Meeder JG, Prins M, Pinto YM.
    J Am Coll Cardiol; 2010 Dec 14; 56(25):2090-100. PubMed ID: 21144969
    [Abstract] [Full Text] [Related]

  • 13. Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial.
    Huijts M, van Oostenbrugge RJ, Duits A, Burkard T, Muzzarelli S, Maeder MT, Schindler R, Pfisterer ME, Brunner-La Rocca HP, TIME-CHF Investigators.
    Eur J Heart Fail; 2013 Jun 14; 15(6):699-707. PubMed ID: 23384944
    [Abstract] [Full Text] [Related]

  • 14. N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial.
    Lainchbury JG, Troughton RW, Strangman KM, Frampton CM, Pilbrow A, Yandle TG, Hamid AK, Nicholls MG, Richards AM.
    J Am Coll Cardiol; 2009 Dec 29; 55(1):53-60. PubMed ID: 20117364
    [Abstract] [Full Text] [Related]

  • 15. Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
    Felker GM, Anstrom KJ, Adams KF, Ezekowitz JA, Fiuzat M, Houston-Miller N, Januzzi JL, Mark DB, Piña IL, Passmore G, Whellan DJ, Yang H, Cooper LS, Leifer ES, Desvigne-Nickens P, O'Connor CM.
    JAMA; 2017 Aug 22; 318(8):713-720. PubMed ID: 28829876
    [Abstract] [Full Text] [Related]

  • 16. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.
    Jourdain P, Jondeau G, Funck F, Gueffet P, Le Helloco A, Donal E, Aupetit JF, Aumont MC, Galinier M, Eicher JC, Cohen-Solal A, Juillière Y.
    J Am Coll Cardiol; 2007 Apr 24; 49(16):1733-9. PubMed ID: 17448376
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.
    Pufulete M, Maishman R, Dabner L, Mohiuddin S, Hollingworth W, Rogers CA, Higgins J, Dayer M, Macleod J, Purdy S, McDonagh T, Nightingale A, Williams R, Reeves BC.
    Health Technol Assess; 2017 Aug 24; 21(40):1-150. PubMed ID: 28774374
    [Abstract] [Full Text] [Related]

  • 18. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
    Feola M, Aspromonte N, Milani L, Bobbio M, Bardellotto S, Barro S, Giovinazzo P, Noventa F, Valle R.
    J Card Fail; 2008 Jun 24; 14(5):420-5. PubMed ID: 18514935
    [Abstract] [Full Text] [Related]

  • 19. The Importance of Worsening Heart Failure in Ambulatory Patients: Definition, Characteristics, and Effects of Amino-Terminal Pro-B-Type Natriuretic Peptide Guided Therapy.
    Mallick A, Gandhi PU, Gaggin HK, Ibrahim N, Januzzi JL.
    JACC Heart Fail; 2016 Sep 24; 4(9):749-55. PubMed ID: 27179830
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
    Bruch C, Fischer C, Sindermann J, Stypmann J, Breithardt G, Gradaus R.
    Am J Cardiol; 2008 Aug 15; 102(4):469-74. PubMed ID: 18678308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.